Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Akebia Therapeutics (AKBA) Short-Term Debt repayments (2019)

Historic Short-Term Debt repayments for Akebia Therapeutics (AKBA) over the last 1 years, with Q1 2019 value amounting to $15.0 million.

  • Akebia Therapeutics' Short-Term Debt repayments changed N/A to $15.0 million in Q1 2019 from the same period last year, while for Dec 2019 it was $15.0 million, marking a year-over-year change of. This contributed to the annual value of $32.0 million for FY2023, which is 303.03% down from last year.
  • According to the latest figures from Q1 2019, Akebia Therapeutics' Short-Term Debt repayments is $15.0 million.
  • Over the past 5 years, Akebia Therapeutics' Short-Term Debt repayments peaked at $15.0 million during Q1 2019, and registered a low of $15.0 million during Q1 2019.